These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised evidence. HIV Trialists' Collaborative Group. Lancet; 1999 Jun; 353(9169):2014-25. PubMed ID: 10376616 [TBL] [Abstract][Full Text] [Related]
12. Immediate versus deferred zidovudine. Saah AJ Lancet; 1993 Apr; 341(8851):1023. PubMed ID: 8096901 [No Abstract] [Full Text] [Related]
13. Long-term follow-up of randomized trials of immediate versus deferred zidovudine in symptom-free HIV infection. Joint Concorde and Opal Coordinating Committee. AIDS; 1998 Jul; 12(11):1259-65. PubMed ID: 9708404 [No Abstract] [Full Text] [Related]
14. Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment. Walker AS; White IR; Babiker AG Stat Med; 2004 Feb; 23(4):571-90. PubMed ID: 14755390 [TBL] [Abstract][Full Text] [Related]
15. Proton Spectroscopy in a Cross-Section of HIV-Positive Asymptomatic Patients Receiving Immediate Compared with Deferred Zidovudine (Concorde Study). Hall-Craggs MA; Williams IG; Wilkinson ID; Paley M; Chinn RJ; Chong WK; Kendall BE; Harrison MJ; Baldeweg T; Pugh K; Riccio M; Catalan J; Weller IV J NeuroAIDS; 1997; 1(3):103-13. PubMed ID: 16873173 [TBL] [Abstract][Full Text] [Related]